The paper addresses the challenge of scheduling multiple output priority queues of a switch in a real-world setting characterized by bursty traffic and diverse traffic priorities. Existing queue ...

A gene therapy for hearing loss, an experimental pancreatic cancer treatment and seven other medications have been chosen as the first recipients of a new voucher the Food and Drug Administration is ...

SEVASTOPOL, Crimea, Sept 26 (Reuters) - A long queue of cars outside a petrol station in Sevastopol, a port city in Russian-controlled Crimea, laid bare the challenges drivers across Russia are facing ...

ALPHARETTA, Ga.--(BUSINESS WIRE)--Priority Technology Holdings, Inc. (NASDAQ: PRTH) ("Priority" or the "Company"), the payments and banking solution that streamlines collecting, storing, lending and ...

When I first hopped on the new Priority Skyline Smart‑Shift e-bike, I wasn’t exactly sure what to expect. I’ve ridden dozens and dozens of commuter e-bikes, some fancier than others, but it’s rare to ...

Taking a majority share of a Wisconsin cooperative health plan advances Priority Health’s strategy to reach across the Great Lakes region. The deal for the member-owned Group Health Cooperative of Eau ...

The FDA has begun accepting applications for a priority pathway designed to slash review times to between one and two months, giving developers of medicines that align with U.S. national health ...

In a market full of complicated tech, sky-high torque specs, and smartphone apps to control an e-bike, New York-based Priority Bicycles is going in the opposite direction with the launch of its newest ...

The Priority Current Plus E-bike is the perfect all-around electric bike, perfect for beginners and seasoned commuters alike. At just 55 pounds, it's compatible with most hitch racks—perfect for use ...

There are several things a good e-commuter bike should have, and Priority’s Current Plus is one of those bikes that ticks all the boxes. Boasting a powerful mid-drive motor, a 720Wh battery, a 5-speed ...

The FDA is introducing a new priority voucher program designed to shorten the drug review process from 10 to 12 months down to one or two months, according to the agency. The federal outfit’s ...